Alcohol use disorder treatment study for veterans
Part of Mental health clinical trials.
This study tests a medication called AAT (acamprosate) to help veterans with alcohol use disorder reduce drinking and stay sober. Participation includes 12 weeks of treatment with study medicine and some study visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be fluent in English
- You must have a primary diagnosis of alcohol use disorder and have been sober for 90 days or less
- If you take psychotropic medications, your dose must have been stable for 4 weeks
- You must not have been diagnosed with psychotic or bipolar disorder
- You must not have a history of moderate or severe traumatic brain injury or other neurological conditions
- You must be able to have an MRI scan (if you join the scanning part of the study)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a non-invasive device that gently stimulates a nerve in your neck (the vagus nerve) to see if it can help reduce alcohol cravings and improve daily functioning. It is designed for veterans who struggle with heavy drinking and want to explore a new treatment option.
This study is for veterans with alcohol use disorder who have been sober for 5 days to 3 weeks. It looks at how trauma, inflammation, and brain function relate to alcohol problems and how well treatment works. You will be in a group that gets medication or a placebo.
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
This study tests whether MDMA-assisted therapy can help veterans who have both PTSD and alcohol use disorder. If you have tried a standard therapy before and want to reduce or stop drinking, this treatment may offer a new option.
This study tests whether a medication called disulfiram (Antabuse) can help people with alcohol use disorder (AUD) feel less anxious when they stop drinking. Researchers will also use brain scans (MRI) to look at how the brain changes during early abstinence.
This study tests a brief treatment delivered by video that involves a Veteran and a concerned family member or friend. It’s meant for Veterans with ongoing alcohol problems, to see if family involvement helps them change drinking and stay safe during treatment.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.